Boston Scientific or its subsidiary filed Intent to Use Trademark Application TM99295958 for SPACEOAR FLEX with the USPTO on July 22, 2025. The trademark covers two product categories: (1) pharmaceutical preparations consisting of pliable, synthetic implantable hydrogel for medical and surgical treatment of prostate cancer, and (2) a medical device comprising pre-polymerized hydrogel for use in prostate cancer treatment procedures.

This is a routine trademark filing that does not impose compliance obligations on third parties. Competitors in the medical hydrogel or prostate cancer treatment device space should review the trademark description to ensure their products do not infringe on the applied-for mark. The Intent to Use basis means the applicant has 3 years from approval to begin use in commerce, extendable to March 31, 2026.